一致性-话题@MedSci

#一致性#

148篇内容 | 2957人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1906920, encodeId=00bf1906920c4, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=奥司他韦，通过一致性评价, objectType=article, longId=160788, objectId=efa0160e8845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efa0160e8845, replyNumber=0, likeNumber=80, createdTime=2019-11-15, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efa0160e8845, moduleTitle=奥司他韦，通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efa0160e8845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906924, encodeId=cb51190692471, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=全新仿制药一致性评价通过品规汇总：受理号破千通过数超200, objectType=article, longId=163263, objectId=27fb16326399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27fb16326399, replyNumber=0, likeNumber=32, createdTime=2019-08-17, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27fb16326399, moduleTitle=全新仿制药一致性评价通过品规汇总：受理号破千通过数超200, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27fb16326399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906934, encodeId=f1f3190693441, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=化学药品注射剂仿制药一致性评价技术要求征求意见, objectType=article, longId=181345, objectId=f93918134574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f93918134574, replyNumber=0, likeNumber=60, createdTime=2020-06-07, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f93918134574, moduleTitle=化学药品注射剂仿制药一致性评价技术要求征求意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f93918134574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906910, encodeId=6d9c190691050, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=2018通过一致性评价的医药盘点, objectType=article, longId=156577, objectId=e93a1565e74e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93a1565e74e, replyNumber=0, likeNumber=71, createdTime=2019-05-22, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93a1565e74e, moduleTitle=2018通过一致性评价的医药盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e93a1565e74e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906917, encodeId=88c8190691e2b, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=INT J LAB HEMATOL：外周血涂片评估中的实时远程数字显微镜检查----观察者内部的一致性和经验, objectType=article, longId=159379, objectId=6c471593e9a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c471593e9a7, replyNumber=0, likeNumber=68, createdTime=2019-02-11, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c471593e9a7, moduleTitle=INT J LAB HEMATOL：外周血涂片评估中的实时远程数字显微镜检查----观察者内部的一致性和经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c471593e9a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906931, encodeId=99cd19069310b, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=国家卫健委：建立耗材一致性评价机构, objectType=article, longId=177642, objectId=89ea1e764294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ea1e764294, replyNumber=0, likeNumber=64, createdTime=2019-09-11, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ea1e764294, moduleTitle=国家卫健委：建立耗材一致性评价机构, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89ea1e764294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906912, encodeId=3ba81906912f2, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=回首2018：那些经过一致性评价的药物, objectType=article, longId=156589, objectId=9d5c15658912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d5c15658912, replyNumber=0, likeNumber=62, createdTime=2019-09-15, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d5c15658912, moduleTitle=回首2018：那些经过一致性评价的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d5c15658912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906922, encodeId=ed431906922b8, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=生死较量！未过一致性评价品种面临两大暴击, objectType=article, longId=162392, objectId=fe2916239264, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2916239264, replyNumber=0, likeNumber=68, createdTime=2019-12-30, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2916239264, moduleTitle=生死较量！未过一致性评价品种面临两大暴击, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2916239264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906923, encodeId=9541190692301, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=带量采购配套一致性评价倒逼药企开启兼并战？, objectType=article, longId=162565, objectId=75f916256549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75f916256549, replyNumber=0, likeNumber=0, createdTime=2020-02-29, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75f916256549, moduleTitle=带量采购配套一致性评价倒逼药企开启兼并战？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75f916256549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906890, encodeId=fbd3190689099, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=一致性评价后医药市场格局, objectType=article, longId=148110, objectId=1df514811051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1df514811051, replyNumber=0, likeNumber=65, createdTime=2018-10-24, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1df514811051, moduleTitle=一致性评价后医药市场格局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1df514811051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906897, encodeId=f139190689e14, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=又一省发文，未过一致性评价不采购, objectType=article, longId=150853, objectId=5d4c1508539b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d4c1508539b, replyNumber=0, likeNumber=68, createdTime=2018-10-30, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d4c1508539b, moduleTitle=又一省发文，未过一致性评价不采购, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d4c1508539b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906926, encodeId=77b5190692663, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=通过一致性评价来那度胺上市，价格为原研药的两成, objectType=article, longId=167899, objectId=42c116e89921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42c116e89921, replyNumber=0, likeNumber=61, createdTime=2020-02-01, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42c116e89921, moduleTitle=通过一致性评价来那度胺上市，价格为原研药的两成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42c116e89921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906889, encodeId=0f881906889fb, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=这省未过一致性药品暂时安全了, objectType=article, longId=147758, objectId=50e414e7584f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50e414e7584f, replyNumber=0, likeNumber=74, createdTime=2019-06-09, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50e414e7584f, moduleTitle=这省未过一致性药品暂时安全了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50e414e7584f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906885, encodeId=2300190688580, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=未通过一致性评价不再采购！国家为何这么做, objectType=article, longId=147331, objectId=4f4c14e33149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f4c14e33149, replyNumber=0, likeNumber=0, createdTime=2019-05-09, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f4c14e33149, moduleTitle=未通过一致性评价不再采购！国家为何这么做, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f4c14e33149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906895, encodeId=c3ce190689551, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=碾压原研？过一致性评价仿制药还有这三道坎, objectType=article, longId=150008, objectId=ba4f1500089e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba4f1500089e, replyNumber=0, likeNumber=70, createdTime=2018-11-01, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba4f1500089e, moduleTitle=碾压原研？过一致性评价仿制药还有这三道坎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba4f1500089e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906884, encodeId=e2ab1906884d8, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=又一省发文，未过一致性评价，暂停挂网, objectType=article, longId=147293, objectId=b7d014e29386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7d014e29386, replyNumber=0, likeNumber=61, createdTime=2019-03-27, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7d014e29386, moduleTitle=又一省发文，未过一致性评价，暂停挂网, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7d014e29386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906882, encodeId=22b9190688292, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=仿制药一致性评价时间节点将至 289种基本药物将何去何从？, objectType=article, longId=145528, objectId=0895145528ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0895145528ae, replyNumber=0, likeNumber=73, createdTime=2019-01-28, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0895145528ae, moduleTitle=仿制药一致性评价时间节点将至 289种基本药物将何去何从？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0895145528ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906893, encodeId=cc3819068931a, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=医疗器械蓝皮书新鲜出炉！中国医疗器械标准与国际标准一致性程度已超90%, objectType=article, longId=148476, objectId=cf5a1484e67e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf5a1484e67e, replyNumber=0, likeNumber=70, createdTime=2019-01-09, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf5a1484e67e, moduleTitle=医疗器械蓝皮书新鲜出炉！中国医疗器械标准与国际标准一致性程度已超90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf5a1484e67e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906916, encodeId=88c319069165d, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=又有重磅药，首家过一致性评价, objectType=article, longId=158355, objectId=07e1158355fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e1158355fa, replyNumber=0, likeNumber=65, createdTime=2019-02-28, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e1158355fa, moduleTitle=又有重磅药，首家过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07e1158355fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906919, encodeId=1a0f190691976, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=18过一致性评价药，比4+7贵几十倍, objectType=article, longId=160267, objectId=c14016026e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14016026e1c, replyNumber=0, likeNumber=138, createdTime=2019-06-23, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14016026e1c, moduleTitle=18过一致性评价药，比4+7贵几十倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14016026e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

一致性

2020-05-29

zhanfl (审核中...)

前往app查看评论内容

#一致性#

奥司他韦，通过一致性评价

2019-11-15

zhanfl (审核中...)

前往app查看评论内容

#一致性#

全新仿制药一致性评价通过品规汇总：受理号破千通过数超200

2019-08-17

zhanfl (审核中...)

前往app查看评论内容

#一致性#

化学药品注射剂仿制药一致性评价技术要求征求意见

2020-06-07

zhanfl (审核中...)

前往app查看评论内容

#一致性#

2018通过一致性评价的医药盘点

2019-05-22

zhanfl (审核中...)

前往app查看评论内容

#一致性#

INT J LAB HEMATOL：外周血涂片评估中的实时远程数字显微镜检查----观察者内部的一致性和经验

2019-02-11

zhanfl (审核中...)

前往app查看评论内容

#一致性#

国家卫健委：建立耗材一致性评价机构

2019-09-11

zhanfl (审核中...)

前往app查看评论内容

#一致性#

回首2018：那些经过一致性评价的药物

2019-09-15

zhanfl (审核中...)

前往app查看评论内容

#一致性#

生死较量！未过一致性评价品种面临两大暴击

2019-12-30

zhanfl (审核中...)

前往app查看评论内容

#一致性#

带量采购配套一致性评价倒逼药企开启兼并战？

2020-02-29

zhanfl (审核中...)

前往app查看评论内容

#一致性#

一致性评价后医药市场格局

2018-10-24

zhanfl (审核中...)

前往app查看评论内容

#一致性#

又一省发文，未过一致性评价不采购

2018-10-30

zhanfl (审核中...)

前往app查看评论内容

#一致性#

通过一致性评价来那度胺上市，价格为原研药的两成

2020-02-01

zhanfl (审核中...)

前往app查看评论内容

#一致性#

这省未过一致性药品暂时安全了

2019-06-09

zhanfl (审核中...)

前往app查看评论内容

#一致性#

未通过一致性评价不再采购！国家为何这么做

2019-05-09

zhanfl (审核中...)

前往app查看评论内容

#一致性#

碾压原研？过一致性评价仿制药还有这三道坎

2018-11-01

zhanfl (审核中...)

前往app查看评论内容

#一致性#

又一省发文，未过一致性评价，暂停挂网

2019-03-27

zhanfl (审核中...)

前往app查看评论内容

#一致性#

仿制药一致性评价时间节点将至 289种基本药物将何去何从？

2019-01-28

zhanfl (审核中...)

前往app查看评论内容

#一致性#

医疗器械蓝皮书新鲜出炉！中国医疗器械标准与国际标准一致性程度已超90%

2019-01-09

zhanfl (审核中...)

前往app查看评论内容

#一致性#

又有重磅药，首家过一致性评价

2019-02-28

zhanfl (审核中...)

前往app查看评论内容

#一致性#

18过一致性评价药，比4+7贵几十倍

2019-06-23

科室
- - 订阅+
  - 更多科室
工具
服务